D-1384-2012 Class III Terminated
FDA drug recall D-1384-2012 was initiated by Teva Pharmaceuticals USA, Inc. on Apr 23, 2012 and is designated Class III. Reason for recall: Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets. The recall status is terminated (terminated Apr 23, 2013). Affected quantity: 40,750 Dispensers.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 27, 2012
- Initiation Date
- Apr 23, 2012
- Termination Date
- Apr 23, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40,750 Dispensers
Product description
Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.
Reason for recall
Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.
Distribution pattern
Nationwide
Code information
Lot #'s 33801826A, Exp 1/2013; 33802144A; 33802323A, Exp 3/2013; 33802519A, Exp 6/2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1384-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026